Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q86WU2
UPID:
LDHD_HUMAN
Alternative names:
-
Alternative UPACC:
Q86WU2; Q8IZK5
Background:
Probable D-lactate dehydrogenase, mitochondrial, encoded by the gene with accession number Q86WU2, plays a crucial role in the catabolic process of D-lactate, distinguishing it from L-lactate. This specificity is vital for metabolic pathways within mitochondria, impacting energy production and cellular health.
Therapeutic significance:
The protein's involvement in D-lactic aciduria with gout, a metabolic disorder characterized by D-lactic aciduria in the presence of normal plasma lactic acid, highlights its potential as a target for therapeutic intervention. Understanding the role of Probable D-lactate dehydrogenase, mitochondrial could open doors to potential therapeutic strategies.